SCHEMBL14112667

SCHEMBL14112667

CCC(C)(C)c1ccc(-c2ccc3c(c2)c2cc4c(cc2n3C)c2cc(-c3ccc(C(C)(C)CC)cc3)ccc2n4C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ RXRB P28702 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ HRH3 Q9Y5N1 11/20 0.35
▸ MAOB P27338 8/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ GRM2 Q14416 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ SENP8 Q96LD8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14112662 0.84 CTSS (0.34) RXRARXRBMAPTGRM2LMNA
SCHEMBL21454582 0.81 KIF11 (0.45) KIF11MAPTKDM4EALDH1A1HPGD
SCHEMBL13867585 0.77 CD38 (0.32) KIF11RXRARXRBMAPTKDM4E
SCHEMBL10133741 0.76 KIF11 (0.50) KIF11MAPTNPC1RAB9AHRH3
SCHEMBL9968158 0.76 GPR3 (0.52) KIF11MAPTNPC1RAB9AKDM4E
SCHEMBL5552840 0.75 NPC1 (0.52) KIF11MAPTNPC1RAB9AHRH3
SCHEMBL3292125 0.75 NPC1 (0.52) KIF11MAPTNPC1RAB9AHRH3
SCHEMBL25523207 0.74 GRM2 (0.44) KIF11RXRARXRBMAPTKDM4E
SCHEMBL13159820 0.74 PGR (0.40) KIF11MAPTKDM4EALDH1A1HPGD
SCHEMBL25058985 0.74 KIF11 (0.53) KIF11RXRARXRBMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207917-A1 POLYMER HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE XEROX CORPORATION (US) 2008-08-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207917-A1 POLYMER HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE SGTA, MTCL3, SMC3 KIF11 1412/4885RXRA 2445/4885RXRB 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback